Fertility preservation and sperm donation in transgender individuals: The current situation within the French CECOS network.


Journal

Andrology
ISSN: 2047-2927
Titre abrégé: Andrology
Pays: England
ID NLM: 101585129

Informations de publication

Date de publication:
11 2021
Historique:
revised: 29 06 2021
received: 09 02 2021
accepted: 29 06 2021
pubmed: 9 7 2021
medline: 3 3 2022
entrez: 8 7 2021
Statut: ppublish

Résumé

Many studies reported that reproductive desire could be high among transgender individuals. In France, fertility preservation and sperm donation were very little proposed to transgender individuals until recently, mainly because the Bioethics Law allows the use of assisted reproductive technologies only in infertile couples and prohibits surrogacy. To evaluate the distribution of care on the French territory concerning fertility preservation and sperm donation in transgender individuals. A multicentric national survey was carried out between January 2019 and October 2020 in 28 assisted reproductive technology centres of the French CECOS (Centres d'Etudes et de Conservation des Oeufs et du Sperme) network. Each centre was questioned to find out how many transgender individuals came, were informed and cared for fertility preservation and sperm donation. Concerning fertility preservation, 71.4% of centres received transgender individuals and performed gamete cryopreservation; 581 transgender individuals consulted for fertility preservation. Transgender women were more likely to desire (p < 0.0001) and achieve (p < 0.0001) fertility preservation than transgender men. Concerning sperm donation in couples including a transgender man, 68% of centres offer the complete course from the first consultation to the completion of the assisted reproductive technology cycles; 122 offsprings have been conceived with sperm donation in couples including a transgender man since 1999. Our results showed that even if all centres do not propose fertility preservation or sperm donation in transgender individuals, these assisted reproductive technologies are present throughout the French territory. The major point is that both fertility preservation and sperm donation in transgender individuals have grown significantly and that the care of these patients is improving year after year. In France, most of CECOS centres can take care of transgender individuals for fertility preservation and sperm donation. The French Bioethics Law allows these latter, and transgender individuals can benefit from a financial support of the national health care insurance for fertility preservation and sperm donation.

Sections du résumé

BACKGROUND
Many studies reported that reproductive desire could be high among transgender individuals. In France, fertility preservation and sperm donation were very little proposed to transgender individuals until recently, mainly because the Bioethics Law allows the use of assisted reproductive technologies only in infertile couples and prohibits surrogacy.
OBJECTIVES
To evaluate the distribution of care on the French territory concerning fertility preservation and sperm donation in transgender individuals.
MATERIALS AND METHODS
A multicentric national survey was carried out between January 2019 and October 2020 in 28 assisted reproductive technology centres of the French CECOS (Centres d'Etudes et de Conservation des Oeufs et du Sperme) network. Each centre was questioned to find out how many transgender individuals came, were informed and cared for fertility preservation and sperm donation.
RESULTS
Concerning fertility preservation, 71.4% of centres received transgender individuals and performed gamete cryopreservation; 581 transgender individuals consulted for fertility preservation. Transgender women were more likely to desire (p < 0.0001) and achieve (p < 0.0001) fertility preservation than transgender men. Concerning sperm donation in couples including a transgender man, 68% of centres offer the complete course from the first consultation to the completion of the assisted reproductive technology cycles; 122 offsprings have been conceived with sperm donation in couples including a transgender man since 1999.
DISCUSSION
Our results showed that even if all centres do not propose fertility preservation or sperm donation in transgender individuals, these assisted reproductive technologies are present throughout the French territory. The major point is that both fertility preservation and sperm donation in transgender individuals have grown significantly and that the care of these patients is improving year after year.
CONCLUSION
In France, most of CECOS centres can take care of transgender individuals for fertility preservation and sperm donation. The French Bioethics Law allows these latter, and transgender individuals can benefit from a financial support of the national health care insurance for fertility preservation and sperm donation.

Identifiants

pubmed: 34236139
doi: 10.1111/andr.13075
doi:

Types de publication

Evaluation Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1790-1798

Informations de copyright

© 2021 American Society of Andrology and European Academy of Andrology.

Références

Coleman E, Bockting W, Botzer M, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgend. 2012;13:165-232.
Zucker KJ. Epidemiology of gender dysphoria and transgender identity. Sex Health. 2017;14(5):404-411.
Baram S, Myers SA, Yee S, Librach CL. Fertility preservation for transgender adolescents and young adults: a systematic review. Hum Reprod Update. 2019;25(6):694-716.
Feigerlová E, Pascal V, Ganne-Devonec M-O, Klein M, Guerci B. Fertility desires and reproductive needs of transgender people: challenges and considerations for clinical practice. Clin Endocrinol (Oxf). 2019;91(1):10-21.
Light AD, Obedin-Maliver J, Sevelius JM, Kerns JL. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol. 2014;124(6):1120-1127.
WPATH (World Professional Association for Transgender Health) Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People 7th version 2011. https://www.wpath.org/publications/soc. Accessed November 21, 2017.
Haute Autorité de santé. Situation actuelle et perspectives d’évolution de la prise en charge médicale du transsexualisme en France. Evaluation des technologies de la santé. HAS 18 Février 2010. https://www.has-sante.fr/
Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017;102(11):3869-3903.
De Wert G, Dondorp W, Shenfield F, et al. ESHRE Task Force on Ethics and Law 23: medically assisted reproduction in singles, lesbian and gay couples, and transsexual people. Hum Reprod. 2014;29(9):1859-1865.
von Doussa H, Power J, Riggs D. Imagining parenthood: the possibilities and experiences of parenthood among transgender people. Cult Health Sex. 2015;17(9):1119-1131.
Light A, Wang L-F, Zeymo A, Gomez-Lobo V. Family planning and contraception use in transgender men. Contraception. 2018;98(4):266-269.
Tornello SL, Bos H. Parenting intentions among transgender individuals. LGBT Health. 2017;4(2):115-120.
De Sutter P, Kira K, Verschoor A, Hotimsky A. The desire to have children and the preservation of fertility in transsexual women: a survey. Int J Transgend. 2002;6:97-103.
Wierckx K, Van Caenegem E, Pennings G, et al. Reproductive wish in transsexual men. Hum Reprod. 2012;27:483-487.
Condat A, Mendes N, Drouineaud V, et al. Biotechnologies that empower transgender persons to self-actualize as individuals, partners, spouses, and parents are defining new ways to conceive a child: psychological considerations and ethical issues. Philos Ethics Humanit Med. 2018;13:1-11.
Pepping CA, Cronin TJ, Halford WK, Lyons A. Minority stress and same-sex relationship satisfaction: the role of concealment motivation. Fam Process. 2019;58(2):496-508.
Wierckx K, Stuyver I, Weyers S, et al. Sperm freezing in transsexual women. Arch Sex Behav. 2012;41:1069-1071.
Strang JF, Jarin J, Call D, et al. Transgender youth fertility attitudes questionnaire: measure development in nonautistic and autistic transgender youth and their parents. J Adolesc Health. 2018;62(2):128-135.
Riggs DW, Bartholomaeus C. Fertility preservation decision making amongst Australian transgender and non-binary adults. Reprod Health. 2018;15(1):181.
Ethics Committee of the American Society for Reproductive Medicine. Access to fertility services by transgender persons: an Ethics Committee opinion. Fertil Steril. 2015;104:1111-1115.
Committee on Adolescent Health Care of the American College of Obstetricians and Gynecologists. Committee opinion no. 685: care for transgender adolescents. Obstet Gynecol. 2017;129:e11-e16.
French Bioethics Law n° 94-654 of July 29, 1994. https://www.juridique-biomedecine.fr/uploads/documents/loi-n-94-654-du-29-juillet-1994-relative-au-don-et--l-utilisation-deslments-et-produits-du-corps-humain--l-assistance-mdicale--la-procration-et-au-diagnostic-prnatal-modifie-loi-n-2004-800-du-6-aot-2.pdf
French Bioethics Law n° 2004-800 of August 6, 2004. https://www.juridique-biomedecine.fr/uploads/documents/loi-n-2004-800-du-6-aot-2004-relative--la-biothique.pdf
French Bioethics Law n° 2011-814 of July 7, 2011. https://www.juridique-biomedecine.fr/uploads/documents/loi-n-2011-814-du-7-juillet-2011-relative--la-biothique-jo-08-07.pdf
Bujan L. The CECOS history: a collective work. Rev Prat. 2018;68(2):225-229.
CECOS. https://www.cecos.org. Accessed October 11, 2019.
https://www.agence-biomedecine.fr. Accessed July 18, 2012.
Chiland C, Clouet A-M, Guinot M, Golse B, Jouannet P, Revidi P. Pères d'un nouveau genre et leurs enfants. La Psychiatrie de L'enfant. 2013;56(1):97.
Chiland C, Clouet AM, Golse B, Guinot M, Wolf JP. A new type of family: transmen as fathers thanks to donor sperm insemination: a 12-year follow-up exploratory study of their children. Neuropsychiatr Enfance Adolesc. 2013;61(6):365-370.
Décision-cadre du Défenseur des droits n°2015-228. https://juridique.defenseurdesdroits.fr/doc_num.php?explnum_id=13603
Décision-cadre du Défenseur des droits n°2020-136. https://www.defenseurdesdroits.fr/sites/default/files/atoms/files/decision_cadre_ndeg2020-136_1.pdf
Chiniara LN, Viner C, Palmert M, Bonifacio H. Perspectives on fertility preservation and parenthood among transgender youth and their parents. Arch Dis Child. 2019;104:739-744.
Brik T, Vrouenraets L, See S, Meissner A, de Vries MC, Hannema SE. Use of fertility preservation among a cohort of transgirls in the Netherlands. J Adolesc Health. 2019;64:589-593.
Jones CA, Reiter L, Greenblatt E. Fertility preservation in transgender patients. Int J Transgend. 2016;17(2):76-82.
Nahata L, Tishelman AC, Caltabellotta NM, Quinn GP. Low fertility preservation utilization among transgender youth. J Adolesc Health. 2017;61(1):40-44.
Chen D, Simons L, Johnson EK, Lockart BA, Finlayson C. Fertility preservation for transgender adolescents. J Adolesc Health. 2017;61(1):120-123.
Barnard EP, Dhar CP, Rothenberg SS, et al. Fertility preservation outcomes in adolescent and young adult feminizing transgender patients. Pediatrics. 2019;144(3):e20183943.
Pang KC, Peri AJS, Chung HE, et al. Rates of fertility preservation use among transgender adolescents. JAMA Pediatr. 2020;174(9):890.
James-Abra S, Tarasoff LA, Green D, et al. Trans people's experiences with assisted reproduction services: a qualitative study. Hum Reprod. 2015;30(6):1365-1374.
Anderson RA, Amant F, Braat D, et al. ESHRE guideline: female fertility preservation. Hum Reprod Open. 2020;4:hoaa052.
Wierckx K, Van Caenegem E, Pennings G, et al. Reproductive wish in transsexual men. Hum Reprod. 2012;27(2):483-487.
Defreyne J, Van Schuylenbergh J, Motmans J, Tilleman KL, T'Sjoen GGR. Parental desire and fertility preservation in assigned female at birth transgender people living in Belgium. Fertil Steril. 2020;113(1):149-157.
Shenfield F, de Mouzon J, Pennings G, et al. Cross border reproductive care in six European countries. Hum Reprod. 2010;25(6):1361-1368.
Ethics Committee of the American Society for Reproductive Medicine. Cross-border reproductive care: an Ethics Committee opinion. Fertil Steril. 2016;106(7):1627-1633.

Auteurs

Florence Eustache (F)

Service D'Histologie-Embryologie, Cytogénétique, Biologie de La Reproduction/CECOS, Site Jean Verdier, Hôpitaux Universitaires Paris Seine-Saint-Denis, Bondy, France.

Véronique Drouineaud (V)

Service de Biologie de la Reproduction-CECOS, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP) Centre, Université de Paris, Paris, France.

Nicolas Mendes (N)

Service D'Histologie-Embryologie, Cytogénétique, Biologie de La Reproduction/CECOS, Site Jean Verdier, Hôpitaux Universitaires Paris Seine-Saint-Denis, Bondy, France.

Béatrice Delépine (B)

CECOS Champagne-Ardenne, Chu de Reims Hôpital d'Enfants, Reims, France.

Charlotte Dupont (C)

CECOS Paris TENON Hôpital, Tenon, Paris, France.

Sophie Mirallié (S)

CECOS Pays de la Loire Nantes Service de Biologie de la reproduction, Nantes, France.

Aline Papaxanthos (A)

CECOS Aquitaine, BORDEAUX Maternité CHU Pellegrin, Bordeaux, France.

Catherine Metzler-Guillemain (C)

CECOS Provence Alpes Côte d'Azur, MARSEILLE CHU La conception, Marseille, France.

Aurélie Rives-Feraille (A)

Normandie Univ, UNIROUEN, EA 4308 'Gametogenesis and Gamete Quality', Rouen University Hospital, Biology of Reproduction-CECOS Laboratory, Rouen, France.

Fanny Magnan (F)

Service D'Histologie-Embryologie, Cytogénétique, Biologie de La Reproduction/CECOS, Site Jean Verdier, Hôpitaux Universitaires Paris Seine-Saint-Denis, Bondy, France.

Cécile Grèze (C)

CECOS Alsace, STRASBOURG CMCO, Schiltighem, France.

Sylviane Hennebicq (S)

CECOS Rhône Alpes, GRENOBLE Hôpital Couple Enfant CHU, Grenoble, France.

Isabelle Koscinski (I)

CECOS Lorraine Nancy, Maternité régionale Universitaire, Nancy, France.

Hortense Drapier (H)

Biologie de la Reproduction-CECOS, Hôpital de La Cavale Blanche, Brest, France.

Cynthia Frapsauce (C)

Service de Médecine et Biologie de la Reproduction-Cecos, CHRU Bretonneau, Tours, France.

Anne Mayeur (A)

CECOS Paris BECLERE, Hôpital Antoine Béclère, Clamart, France.

Marie-Ange Carlotti (MA)

CECOS Basse Normandie CAEN CHU de Caen, Caen, France.

Joffrey Mons (J)

CECOS Océan Indien LA REUNION Centre, d'AMP CHU de La Réunion, Saint-Pierre, France.

Françoise Schmitt (F)

CECOS ALSACE Mulhouse Groupe Hospitalier, de la Région de Mulhouse et Sud Alsace, Mulhouse, France.

Pascale May-Panloup (P)

CECOS Pays de Loire, Antenne Angers, Laboratoire de Biologie de la Reproduction, Angers University Hospital, Angers, France.

Oxana Blagosklonov (O)

Service de Biologie et Médecine, de la Reproduction-Cryobiologie, CECOS CHRU Jean Minjoz, Besancon, France.

Florence Brugnon (F)

CECOS Auvergne, Clermont FERRAND CHU Estaing, Clermont, France.

Stéphanie Mestres (S)

CECOS Auvergne, Clermont FERRAND CHU Estaing, Clermont, France.

Rosalie Cabry (R)

CECOS Picardie AMIENS, Amiens, France.

Patricia Fauque (P)

CECOS Franche Comté Bourgogne, Dijon, France.

Vanessa Loup-Cabaniols (V)

CECOS Languedoc Roussillon, MONTPELLIER Hôpital Arnaud de Villeneuve, Montpellier, France.

Célia Ravel (C)

CECOS Bretagne, RENNES Hôpital Sud, Rennes, France.

Rachel Lévy (R)

CECOS Paris TENON Hôpital, Tenon, Paris, France.

Catherine Patrat (C)

Service de Biologie de la Reproduction-CECOS, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP) Centre, Université de Paris, Paris, France.

Emmanuelle Thibault (E)

CECOS Provence Alpes, Côte d'Azur NICE Centre de reproduction CHU de NICE, Nice, France.

Nelly Frydman (N)

CECOS Paris BECLERE, Hôpital Antoine Béclère, Clamart, France.

Louis Bujan (L)

CECOS Midi Pyrénées, TOULOUSE Hôpital Paule de Viguier, Toulouse, France.

Catherine Morinière (C)

CECOS Caraïbes, PMA CHU Guadeloupe, Pointe-a-Pitre, France.

Bérengère Ducrocq (B)

CECOS Nord LILLE CHRU, de LILLE Hôpital Calmette, Lille, France.

Nathalie Rives (N)

Normandie Univ, UNIROUEN, EA 4308 'Gametogenesis and Gamete Quality', Rouen University Hospital, Biology of Reproduction-CECOS Laboratory, Rouen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH